2015 - Dr. Dorian R.A. Swarts

University of York UK, Award co-sponsored by Eli Lilly Netherlands, Award winning subject: Molecular profiling of pulmonary carcinoids, insight into tumor biology and identification of prognostic markers (University of Maastricht, december 2013)’. 

 

2013 - Dr. Kevin Hollevoet

Research Fellow at Nattional Cancer Institute Bethseda, Maryland, USA, Award co-sponsored by Eli Lilly Netherlands, Award winning subject: The role of blood protein biomarkers in the management of malignant pleural mesothelioma (Gent University)

 

2011 - Dr Maarten Titulaer

Leiden University Medical Center. Award co-sponsored by Eli Lilly. Award winning subject: Prediction of small cell lung cancer in the Lambert Eaton myasthenic syndrome.

 

2009 - Dr. Anja Timmer-Bonte

Radboud hospital and University of Nijmegen, Lung Diseases Centre Dekkerswald. Award co-sponsored by Eli Lilly Netherlands. Award winning subject: Effective Chemotherapy Support, a matter of timing and combining.

 

2007 - Dr Judith Herder

Free University of Amsterdam. Award co-sponsored by Eli Lilly Netherlands. Award winning subject: The use of 18 FDG PET in NSCLC. 

 

2005 - Dr Paul Wirtz

Leiden University Medical Center. Award co-sponsored by Schering Plough. Award winning subject: research on autoimmunity, associated with small cell lung cancer and the Lambert-Eaton myasthenia syndrome.

 

2003 - Dr Corneline Hoekstra

Free University of Amsterdam. Award co-sponsored by Schering Plough. Award winning subject: Monitoring response to therapy in locally advanced non-small cell lunge cancer using Positron Emission Tomography, clinical aspects and methodology.

 

2001 - Dr. Anne-Marie Dingemans

Free University of Amsterdam. Award winning subject: The role of topoisomerases in lung cancer.

 

1999 - Dr. Veerle Somers

University of Groningen. Award winning subject: Research on mutations of the oncogen K-ras.

 

1997 - Dr. Egbert Smit

University of Groningen. Award winning subject: Research on new chemothereupical agents, the development of essays for tumor response, and an anti-lungcancer antibody